Phage-Derived Fully Human Monoclonal Antibody Fragments to Human Vascular Endothelial Growth Factor-C Block Its Interaction with VEGF Receptor-2 and 3

Matthias Rinderknecht, Alessandra Villa, Kurt Ballmer-Hofer et al. · 2010

Read Phage-Derived Fully Human Monoclonal Antibody Fragments to Human Vascular Endothelial Growth Factor-C Block Its Interaction with VEGF Receptor-2 and 3 by Matthias Rinderknecht, Alessandra Villa, Kurt Ballmer-Hofer et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011941.txt.

Description

Matthias Rinderknecht and co-workers built in 2010 antibody fragments aimed at a vessel growth signal linked to cancer spread. VEGF-C drives the growth of lymphatic vessels, and tumors rich in it show more vessel density, more invasion into those vessels, and more spread to lymph nodes. The signal works through two receptors, VEGFR-2 and VEGFR-3.

Using phage display, the team produced fully human antibody fragments that block VEGF-C from engaging either receptor. Blocking the signal at its source could slow the lymphatic route that many tumors use to spread. Human fragments are attractive drug material because the body is less likely to react against them.

Catalog record

CREATORMatthias Rinderknecht, Alessandra Villa, Kurt Ballmer-Hofer et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011941

Browse the full library · About the Tower of Babel